Search Results
Nov 26, 2025, 05:28 ET Il Gruppo Menarini annuncia che, al 67° Congresso Annuale dell'American Society of Hematology, presenterà nuovi dati su ELZONRIS® (tagraxofusp-erzs)
617. Acute Myeloid Leukemias: Commercially Available Therapies: Manifesto IIIPresentazione del manifesto
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 26, 2025, 04:00 ET Hisense liderem globalnego rynku telewizorów 100-calowych i Laser TV w III kw. 2025 r.
100-calowych i większych, zdobywając 56,6% udziału w rynku dostaw oraz w segmencie urządzeń Laser TV, gdzie udział w dostawach wyniósł 68.9%. Są to wyniki dla III kw. 2025 r. oparte o najnowsze dane opublikowane przez Omdia. Potwierdzają one, że Hisense jest liderem branży dzięki ciągłym innowacjom i doskonałemu
More news about: Hisense
Nov 26, 2025, 01:00 ET Renalys Pharma Announces Positive Topline Results from Phase III Study of Sparsentan in Japanese Patients with IgA Nephropathy
2025 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") today announced positive topline results from its Phase III clinical study of sparsentan (development code: RE-021), an orally administered dual endothelin and angiotensin II receptor antagonist (DEARA), in Japanese
More news about: Renalys Pharma, Inc.
Nov 25, 2025, 16:30 ET NOAH HOLDINGS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025
primarily consisted of (i) compensation and benefits of RMB319.8 million (US$44.9 million); (ii) selling expenses of RMB68.6 million (US$9.6 million); (iii) general and administrative expenses of RMB71.9 million (US$10.1 million); (iv) provision for credit losses of RMB4.7 million (US$0.7 million); (v) other
More news about: Noah Holdings Limited
Nov 25, 2025, 16:05 ET Petco Reports Third Quarter 2025 Financial Results
from multi-channel retailers, mass and grocery retailers, and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments;
More news about: Petco - Investor Relations
Nov 25, 2025, 16:02 ET CleanSpark Reports Transformative FY 2025 Results
performance, and for which the accounting requires management judgment, and the resulting expenses could vary significantly in comparison to other companies; (iii) non-cash impairment losses related to long-lived assets (including goodwill); (iv) realized gains and losses on sales of equity securities, the amounts
More news about: CleanSpark, Inc.
Nov 25, 2025, 16:01 ET Workday Announces Fiscal 2026 Third Quarter Financial Results
infrastructure operations; (ii) service outages, delays in the deployment of our applications, and the failure of our applications to perform properly; (iii) privacy concerns and evolving domestic or foreign laws and regulations; (iv) the impact of continuing global economic and geopolitical volatility on
More news about: Workday Inc.
Nov 25, 2025, 15:30 ET STUB INVESTOR ALERT: StubHub Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead the StubHub Class Action Lawsuit
timing of payments to vendors; (ii) those changes had a significant adverse impact on free cash flow, including trailing 12 months free cash flow; and (iii) as a result, StubHub's free cash flow reports were materially misleading. The quarterly report allegedly revealed that this year-over-year
More news about: Robbins Geller Rudman & Dowd LLP
Nov 25, 2025, 13:04 ET The Propane Council of Texas Serves Up Tips for Thanksgiving Day
heating the appliance.Establish a Buffer Zone: Keep children and pets safely away from all active cooking zones.III. Outdoor Turkey Frying Safety The Golden Rule: NEVER fry a frozen or partially frozen turkey. Ice and water
More news about: Propane Council of Texas
Nov 25, 2025, 09:45 ET FANBASE AND POCSTOCK PARTNER TO PAY USERS AND MEDIA COMPANIES FOR AI TRAINING OF THEIR CONTENT
content for AI to be trained on. This partnership sets a new standard for compensation in the social media economy.Quote from Isaac Hayes III, Founder and CEO of Fanbase"I am really excited about this partnership because this is exactly what Fanbase stands for. We value the cultural
More news about: Fanbase Social Media Inc.
Nov 25, 2025, 08:45 ET Skye Bioscience, Inc. Class Action: Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
effective than defendants had led investors to believe; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.WHAT'S NEXT? If you suffered a loss
More news about: Levi & Korsinsky, LLP
Nov 25, 2025, 08:45 ET Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (iii) accordingly, defendants' purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (iv) defendants
More news about: Levi & Korsinsky, LLP
Nov 25, 2025, 08:45 ET Class Action Filed Against Firefly Aerospace Inc. (FLY) - January 12, 2026 Deadline to Join - Contact Levi & Korsinsky
for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'
More news about: Levi & Korsinsky, LLP
Nov 25, 2025, 08:42 ET The Legendary Guitars at Hard Rock Casino Tejon: How Gable Delivered a New Tribal Landmark
306-acre resort, symbolizing tribal pride, community investment, and the beginning of a new regional entertainment destination. Chairman Octavio Escobedo III of the Tejon Indian Tribe said, "The rise of the Hard Rock Casino Tejon Guitar Monument marks a sacred moment in the Tejon Indian Tribe's
More news about: Gable
Nov 25, 2025, 08:36 ET Menarini Group 宣佈將於第 67 屆美國血液學會年會暨展覽會 (67th American Society of Hematology Annual Meeting and Exposition) 發表 ELZONRIS® (tagraxofusp-erzs) 最新數據
617. Acute Myeloid Leukemias:Commercially Available Therapies: 海報 III海報演示2025
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 25, 2025, 08:36 ET 6K Additive Secures Approval for $27.4 Million EXIM Loan to assist with Critical Minerals Expansion in Pennsylvania with the Department of War
Cadenazzi, the Assistant Secretary of War for Industrial Base Policy. "This loan also builds upon the Department of War's 2023 Defense Production Act Title III investment in 6K Additive and exemplifies the whole-of-government approach to building and scaling critical mineral capabilities." 1
More news about: 6K
Nov 25, 2025, 08:30 ET YY Group's Thailand Subsidiary Adds JW Marriott to Growing Hotel Client Portfolio
factors include, but are not limited to, (i) growth of the hospitality market in Thailand and Southeast Asia, (ii) capital and credit market volatility, (iii) local and global economic conditions, (iv) our anticipated growth strategies, (v) governmental approvals and regulations, and (vi) our future business
More news about: YY Group Holding Limited
Nov 25, 2025, 08:20 ET Agile Defense Completes Integration of IntelliBridge, Marking a New Phase of Growth, Innovation, and Mission Impact
Digital and Artificial Intelligence Office (CDAO) to provide AI engineering support to the Combatant Commands and Joint Staff, its first SBIR Phase III award supporting the
More news about: Agile Defense
Nov 25, 2025, 08:03 ET Regenity Biosciences Marks 63rd FDA 510(k) Clearance with Expansion of Neurosurgical Portfolio
510(k) clearance for DuraMatrix® Repair – Collagen Dura Regeneration Membrane, a resorbable membrane composed of highly purified Type I and Type III bovine collagen for the repair of dura mater defects during neurosurgery. This latest clearance reinforces Regenity's established regulatory strength
More news about: Regenity Biosciences
Nov 25, 2025, 08:00 ET Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting
fusion protein approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory (r/r) Stage I–III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy. Company representatives will be available throughout the meeting to engage
More news about: Citius Oncology, Inc.
Nov 25, 2025, 07:00 ET Northstar Reports Third Quarter 2025 Financial and Operating Results and Announces Upcoming Investor Conference Call
with future plants due to potentially superior quality characteristics; (ii) the Company's ability to access markets for its solid asphalt pellets; (iii) Northstar's limestone patent to remain in force until 2045; and (iv) Northstar's ability to become a leader in the recovery and reprocessing of asphalt
More news about: Northstar Clean Technologies Inc.
Nov 25, 2025, 06:00 ET Hyperscale Data Bitcoin Treasury at Approximately $70.5 Million
million Bitcoin treasury strategy," stated Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "Our strategy is fundamentally built on the principle of dollar-cost averaging as it not only removes influence
More news about: Hyperscale Data Inc.
Nov 25, 2025, 05:07 ET Menarini Group anuncia nuevos datos sobre ELZONRIS ® (tagraxofusp-erzs) que se presentarán en la 67ª Reunión y Exposición Anual de la Sociedad Americana de Hematología
617. Leucemias mieloides agudas: disponibles comercialmente Terapias: Póster III Presentación de póster
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 25, 2025, 05:04 ET Menarini Group anuncia novos dados sobre ELZONRIS® (tagraxofusp-erzs) a serem apresentados na 67ª Reunião e Exposição Anual da Sociedade Americana de Hematologia
617. Leucemias Mieloides Agudas: Comercialmente disponíveis Terapias: Poster III Apresentação do cartaz
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 25, 2025, 04:53 ET Menarini Group anuncia nuevos datos sobre ELZONRIS® (tagraxofusp-erzs)
617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster III Presentación de póster
More news about: Menarini Industrie Farmaceutiche Riunite